{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T12:28:18Z","timestamp":1763468898898,"version":"build-2065373602"},"reference-count":43,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T00:00:00Z","timestamp":1699315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"A.P. M\u00f8ller og Hustru Chastine Mc-Kinney M\u00f8llers Fond til almene Formaal"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>Bevacizumab is a frequently used inhibitor of vascular endothelial growth factor (VEGF) in the management of macular edema in central retinal vein occlusion (CRVO). Studying retinal protein changes in bevacizumab intervention may provide insights into mechanisms of action. In nine Danish Landrace pigs, experimental CRVO was induced in both eyes with argon laser. The right eyes received an intravitreal injection of 0.05 mL bevacizumab (n = 9), while the left control eyes received 0.05 mL saline water (NaCl). Retinal samples were collected 15 days after induced CRVO. Label-free quantification nano-liquid chromatography\u2013tandem mass spectrometry identified 59 proteins that were regulated following bevacizumab treatment. Following bevacizumab intervention, altered levels of bevacizumab components, including the Ig gamma-1 chain C region and the Ig kappa chain C region, were observed. Changes in other significantly regulated proteins ranged between 0.58\u20131.73, including for the NADH-ubiquinone oxidoreductase chain (fold change = 1.73), protein-transport protein Sec24B (fold change = 1.71), glycerol kinase (fold change = 1.61), guanine-nucleotide-binding protein G(T) subunit-gamma-T1 (fold change = 0.67), and prefoldin subunit 6 (fold change = 0.58). A high retinal concentration of bevacizumab was achieved within 15 days. Changes in the additional proteins were limited, suggesting a narrow mechanism of action.<\/jats:p>","DOI":"10.3390\/jpm13111580","type":"journal-article","created":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T11:23:39Z","timestamp":1699356219000},"page":"1580","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Proteome Analysis of Bevacizumab Intervention in Experimental Central Retinal Vein Occlusion"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2150-7754","authenticated-orcid":false,"given":"Lasse J\u00f8rgensen","family":"Cehofski","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Odense University Hospital, 5000 Odense, Denmark"},{"name":"Biomedical Research Laboratory, Aalborg University Hospital, 9000 Aalborg, Denmark"},{"name":"Department of Clinical Research, University of Southern Denmark, 5000 Odense, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Kruse","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Aalborg University Hospital, 9000 Aalborg, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mads Odgaard","family":"M\u00e6ng","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Aalborg University Hospital, 9000 Aalborg, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5797-7638","authenticated-orcid":false,"given":"Benedict","family":"Kjaergaard","sequence":"additional","affiliation":[{"name":"Biomedical Research Laboratory, Aalborg University Hospital, 9000 Aalborg, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5019-0736","authenticated-orcid":false,"given":"Jakob","family":"Grauslund","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Odense University Hospital, 5000 Odense, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3459-7429","authenticated-orcid":false,"given":"Bent","family":"Honor\u00e9","sequence":"additional","affiliation":[{"name":"Department of Biomedicine, Aarhus University, 8000 Aarhus, Denmark"},{"name":"Department of Clinical Medicine, Aalborg University, 9000 Aalborg, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Vorum","sequence":"additional","affiliation":[{"name":"Department of Biomedicine, Aarhus University, 8000 Aarhus, Denmark"},{"name":"Department of Clinical Medicine, Aalborg University, 9000 Aalborg, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,11,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000494224","article-title":"Prevalence of Retinal Vein Occlusion in Europe: A Systematic Review and Meta-Analysis","volume":"241","author":"Li","year":"2019","journal-title":"Ophthalmologica"},{"key":"ref_2","first-page":"371","article-title":"Central retinal vein occlusion: A prospective histopathologic study of 29 eyes in 28 cases","volume":"79","author":"Green","year":"1981","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ophtha.2010.04.019","article-title":"Natural history of visual outcome in central retinal vein occlusion","volume":"118","author":"Hayreh","year":"2011","journal-title":"Ophthalmology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(20)31559-2","article-title":"Retinal vascular occlusions","volume":"396","author":"Scott","year":"2020","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/02713680701851902","article-title":"Branch retinal vein occlusion: Pathogenesis, visual prognosis, and treatment modalities","volume":"33","author":"Rehak","year":"2008","journal-title":"Curr. Eye Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1001\/jamaophthalmol.2013.5515","article-title":"Branch retinal vein occlusion: Natural history of visual outcome","volume":"132","author":"Hayreh","year":"2014","journal-title":"JAMA Ophthalmol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1007\/s40123-023-00734-9","article-title":"Foveal Eversion is Associated with High Persistence of Macular Edema and Visual Acuity Deterioration in Retinal Vein Occlusion","volume":"12","author":"Arrigo","year":"2023","journal-title":"Ophthalmol. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/bjophthalmol-2017-311614","article-title":"Neuroretinal atrophy following resolution of macular oedema in retinal vein occlusion","volume":"103","author":"Podkowinski","year":"2019","journal-title":"Br. J. Ophthalmol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.ophtha.2014.04.045","article-title":"Risk factors associated with developing branch retinal vein occlusion among enrollees in a United States managed care plan","volume":"121","author":"Stem","year":"2014","journal-title":"Ophthalmology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.ophtha.2010.01.060","article-title":"Natural history of central retinal vein occlusion: An evidence-based systematic review","volume":"117","author":"McIntosh","year":"2010","journal-title":"Ophthalmology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1167\/iovs.14-15789","article-title":"Role of soluble vascular endothelial growth factor receptor signaling and other factors or cytokines in central retinal vein occlusion with macular edema","volume":"56","author":"Noma","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_12","first-page":"100921","article-title":"Sustained suppression of VEGF for treatment of retinal\/choroidal vascular diseases","volume":"2020","author":"Campochiaro","year":"2020","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Cehofski, L.J., Kruse, A., Kirkeby, S., Alsing, A.N., Ellegaard Nielsen, J., Kojima, K., Honore, B., and Vorum, H. (2018). IL-18 and S100A12 Are Upregulated in Experimental Central Retinal Vein Occlusion. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19113328"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1167\/iovs.61.14.6","article-title":"Aqueous Fibronectin Correlates With Severity of Macular Edema and Visual Acuity in Patients With Branch Retinal Vein Occlusion: A Proteome Study","volume":"61","author":"Cehofski","year":"2020","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1167\/iovs.64.2.23","article-title":"Macular Edema in Central Retinal Vein Occlusion Correlates With Aqueous Fibrinogen Alpha Chain","volume":"64","author":"Cehofski","year":"2023","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1016\/j.ophtha.2011.05.014","article-title":"Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results","volume":"118","author":"Haller","year":"2011","journal-title":"Ophthalmology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.exer.2018.02.029","article-title":"Dexamethasone intravitreal implant downregulates PDGFR-alpha and upregulates caveolin-1 in experimental branch retinal vein occlusion","volume":"171","author":"Cehofski","year":"2018","journal-title":"Exp. Eye Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e674","DOI":"10.1111\/aos.13021","article-title":"The efficacy and safety of intravitreal dexamethasone implants for macular oedema secondary to retinal vein occlusion: 3-year experience","volume":"94","author":"Higham","year":"2016","journal-title":"Acta Ophthalmol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Cehofski, L.J., Kruse, A., M\u00e6ng, M.O., Sejergaard, B.F., Schlosser, A., Sorensen, G.L., Grauslund, J., Honor\u00e9, B., and Vorum, H. (2022). Dexamethasone Intravitreal Implant is Active at the Molecular Level Eight Weeks after Implantation in Experimental Central Retinal Vein Occlusion. Molecules, 27.","DOI":"10.3390\/molecules27175687"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ophtha.2013.08.038","article-title":"Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: The RETAIN study","volume":"121","author":"Campochiaro","year":"2014","journal-title":"Ophthalmology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e2335148","DOI":"10.1001\/jamanetworkopen.2023.35148","article-title":"Intravitreal Vascular Endothelial Growth Factor Inhibitor Therapy in Denmark and 5-Year Projections","volume":"6","author":"Thinggaard","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.oret.2022.11.001","article-title":"Central Retinal Vein Occlusion 36-Month Outcomes with Anti-VEGF: The Fight Retinal Blindness! Registry","volume":"7","author":"Hunt","year":"2023","journal-title":"Ophthalmol. Retin."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10456-011-9249-6","article-title":"Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab","volume":"15","author":"Papadopoulos","year":"2012","journal-title":"Angiogenesis"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e1700394","DOI":"10.1002\/pmic.201700394","article-title":"The Human Eye Proteome Project: Updates on an Emerging Proteome","volume":"18","author":"Ahmad","year":"2018","journal-title":"Proteomics"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.exer.2015.06.011","article-title":"Proteins involved in focal adhesion signaling pathways are differentially regulated in experimental branch retinal vein occlusion","volume":"138","author":"Cehofski","year":"2015","journal-title":"Exp. Eye Res."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Cehofski, L.J., Kruse, A., Alsing, A.N., Sejergaard, B.F., Nielsen, J.E., Schlosser, A., Sorensen, G.L., Grauslund, J., Honor\u00e9, B., and Vorum, H. (2022). Proteome Analysis of Aflibercept Intervention in Experimental Central Retinal Vein Occlusion. Molecules, 27.","DOI":"10.3390\/molecules27113360"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-1-0716-0255-3_3","article-title":"Proteomic Protocols for Differential Protein Expression Analyses","volume":"2110","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/pmic.201300553","article-title":"Suspension trapping (Strap) sample preparation method for bottom-up proteomics analysis","volume":"14","author":"Zougman","year":"2014","journal-title":"Proteomics"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1038\/nprot.2016.136","article-title":"The MaxQuant computational platform for mass spectrometry-based shotgun proteomics","volume":"11","author":"Tyanova","year":"2016","journal-title":"Nat. Protoc."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nmeth.3901","article-title":"The Perseus computational platform for comprehensive analysis of (prote)omics data","volume":"13","author":"Tyanova","year":"2016","journal-title":"Nat. Methods"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"M\u00e6ng, M.O., Roshanth, N., Kruse, A., Nielsen, J.E., Kj\u00e6rgaard, B., Honor\u00e9, B., Vorum, H., and Cehofski, L.J. (2023). Laser-Induced Porcine Model of Experimental Retinal Vein Occlusion: An Optimized Reproducible Approach. Medicina, 59.","DOI":"10.3390\/medicina59020243"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.4155\/bio.14.227","article-title":"Analytical platforms in vitreoretinal proteomics","volume":"6","author":"Cehofski","year":"2014","journal-title":"Bioanalysis"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1001\/jama.2017.4568","article-title":"Effect of Bevacizumab vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due to Central Retinal Vein Occlusion: The SCORE2 Randomized Clinical Trial","volume":"317","author":"Scott","year":"2017","journal-title":"Jama"},{"key":"ref_34","first-page":"839137","article-title":"Dye-Free Porcine Model of Experimental Branch Retinal Vein Occlusion: A Suitable Approach for Retinal Proteomics","volume":"2015","author":"Cehofski","year":"2015","journal-title":"J. Ophthalmol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3389\/fphar.2018.00649","article-title":"Bevacizumab Diminishes Inflammation in an Acute Endotoxin-Induced Uveitis Model","volume":"9","author":"Almansa","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/bjo.2008.138479","article-title":"Characteristics of severe intraocular inflammation following intravitreal injection of bevacizumab (Avastin)","volume":"93","author":"Georgopoulos","year":"2009","journal-title":"Br. J. Ophthalmol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cellsig.2018.11.007","article-title":"Bevacizumab induces inflammation in MDA-MB-231 breast cancer cell line and in a mouse model","volume":"53","author":"Jalaleddine","year":"2019","journal-title":"Cell. Signal."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/bjo.2009.166033","article-title":"Intraocular inflammation with intravitreal bevacizumab (Avastin)","volume":"94","author":"Raja","year":"2010","journal-title":"Br. J. Ophthalmol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ophtha.2012.07.080","article-title":"A longitudinal analysis of risk factors associated with central retinal vein occlusion","volume":"120","author":"Stem","year":"2013","journal-title":"Ophthalmology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/ceo.13031","article-title":"Prevalence of retinal vein occlusion in the Australian National Eye Health Survey","volume":"46","author":"Keel","year":"2018","journal-title":"Clin. Exp. Ophthalmol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ophtha.2009.08.022","article-title":"The incidence of retinal vein occlusion in the ocular hypertension treatment study","volume":"117","author":"Barnett","year":"2010","journal-title":"Ophthalmology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s10384-020-00717-4","article-title":"Retinal vascular inflammatory and occlusive changes in infectious and non-infectious uveitis","volume":"64","author":"Kaburaki","year":"2020","journal-title":"Jpn. J. Ophthalmol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Lee, J.Y., Wang, S.M., Jeon, S.H., Kim, M.H., Han, K.D., and Roh, Y.J. (2023). The Risk of Retinal Vein Occlusion in Young Patients with Mental Disorders: A Nationwide Cohort Study. J. Clin. Med., 12.","DOI":"10.3390\/jcm12144874"}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/13\/11\/1580\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:18:37Z","timestamp":1760131117000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/13\/11\/1580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,7]]},"references-count":43,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["jpm13111580"],"URL":"https:\/\/doi.org\/10.3390\/jpm13111580","relation":{},"ISSN":["2075-4426"],"issn-type":[{"type":"electronic","value":"2075-4426"}],"subject":[],"published":{"date-parts":[[2023,11,7]]}}}